Literature DB >> 3731102

Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.

M Nakagawa, S Akiyama, T Yamaguchi, N Shiraishi, J Ogata, M Kuwano.   

Abstract

A colchicine resistant clone, Chr-24, derived from the human carcinoma KB cell line is extensively resistant to multiple drugs including vinblastine, vincristine, Adriamycin, actinomycin D, and daunomycin. In comparison with KB cells, very low accumulation of daunomycin or vincristine is observed in multidrug-resistant cells. Two isoprenoids with 9 to 10 isoprene chains (polyprenoids), N-(p-methylbenzyl)decaprenylamine and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine overcame the multidrug resistance almost completely in cultured Chr-24, whereas they only slightly sensitized the parental KB cells to anticancer agents. Both isoprenoids enhance the accumulation of vincristine or daunomycin in Chr-24, possibly by inhibiting efflux and also by enhancing influx of anticancer agents. A verapamil-like structure of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine is discussed in relation to its ability to overcome drug resistance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731102

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Oncology.

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

2.  Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity.

Authors:  T Yoshinari; Y Iwasawa; K Miura; I S Takahashi; T Fukuroda; K Suzuki; A Okura
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Genetics of multidrug resistance.

Authors:  J M Croop; P Gros; D E Housman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 4.  Pharmacologic circumvention of multidrug resistance.

Authors:  J M Ford; W N Hait
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

5.  Vincristine-resistant human cancer KB cell line and increased expression of multidrug-resistance gene.

Authors:  K Kohno; J Kikuchi; S Sato; H Takano; Y Saburi; K Asoh; M Kuwano
Journal:  Jpn J Cancer Res       Date:  1988-11

6.  Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.

Authors:  A Tomida; T Tatsuta; H Suzuki
Journal:  Jpn J Cancer Res       Date:  1991-01

7.  Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.

Authors:  A Kiue; T Sano; A Naito; M Okumura; K Kohno; M Kuwano
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

8.  Potentiation of vincristine by vitamin A against drug-resistant mouse leukaemia cells.

Authors:  I Nogae; J Kikuchi; T Yamaguchi; M Nakagawa; N Shiraishi; M Kuwano
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

9.  Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.

Authors:  S Hasegawa; T Abe; S Naito; S Kotoh; J Kumazawa; D R Hipfner; R G Deeley; S P Cole; M Kuwano
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

10.  Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.

Authors:  Hideki Enokida; Takenari Gotanda; Shoichi Oku; Yoshiharu Imazono; Hiroyuki Kubo; Toshikatsu Hanada; Shigenori Suzuki; Kouhei Inomata; Takao Kishiye; Yoshiyuki Tahara; Kenryu Nishiyama; Masayuki Nakagawa
Journal:  Jpn J Cancer Res       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.